Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bergman

Showing results (701-710 of 904) with videos related to

Pageof 91
Sort By:
European Journal of Gastroenterology & Hepatology|August 6, 2008
Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reportsWouter L Curvers, Femke P Peters, Brenda Elzer, et al.
BMC Medical Education|August 15, 2015
Effects of learning content in context on knowledge acquisition and recall: a pretest-posttest control group designEsther M Bergman, Anique B H de Bruin, Marc A T M Vorstenbosch, et al.
The Annals of Thoracic Surgery|April 14, 2022
Improved Clinical and Survival Outcomes After Esophagectomy for Cancer Over 25 YearsAnnelijn E Slaman, Giovanni Pirozzolo, Wietse J Eshuis, et al.
The Lancet. Gastroenterology & Hepatology|June 24, 2018
Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrett's oesophagus: a multicentre randomised controlled trialRoos E Pouw, Hannah T Künzli, Raf Bisschops, et al.
Elife|December 20, 2019
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growthSander Al Palit, Daniel Vis, Suzan Stelloo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 TrialSarah Baker, Will Jiang, Benjamin Mou, et al.
Neoplasia (New York, N.Y.)|January 16, 2017
Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA studyNikol Snoeren, Richard van Hillegersberg, Sander B Schouten, et al.
Cancer Immunology, Immunotherapy : CII|June 15, 2007
An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancerFrancesca Milano, Agnieszka M Rygiel, Navtej Buttar, et al.
Clinical Genitourinary Cancer|October 29, 2017
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate CancerDaniel Heinrich, Jasmin Bektic, Andries M Bergman, et al.
Glia|April 4, 2022
Survival motor neuron protein deficiency alters microglia reactivityGuzal Khayrullina, Zaida A Alipio-Gloria, Marc-Olivier Deguise, et al.
Pageof 91

Showing results (701-710 of 904) with videos related to

Sort By:
Pageof 91
European Journal of Gastroenterology & Hepatology|August 6, 2008
Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reportsWouter L Curvers, Femke P Peters, Brenda Elzer, et al.
BMC Medical Education|August 15, 2015
Effects of learning content in context on knowledge acquisition and recall: a pretest-posttest control group designEsther M Bergman, Anique B H de Bruin, Marc A T M Vorstenbosch, et al.
The Annals of Thoracic Surgery|April 14, 2022
Improved Clinical and Survival Outcomes After Esophagectomy for Cancer Over 25 YearsAnnelijn E Slaman, Giovanni Pirozzolo, Wietse J Eshuis, et al.
The Lancet. Gastroenterology & Hepatology|June 24, 2018
Simplified versus standard regimen for focal radiofrequency ablation of dysplastic Barrett's oesophagus: a multicentre randomised controlled trialRoos E Pouw, Hannah T Künzli, Raf Bisschops, et al.
Elife|December 20, 2019
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growthSander Al Palit, Daniel Vis, Suzan Stelloo, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 TrialSarah Baker, Will Jiang, Benjamin Mou, et al.
Neoplasia (New York, N.Y.)|January 16, 2017
Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA studyNikol Snoeren, Richard van Hillegersberg, Sander B Schouten, et al.
Cancer Immunology, Immunotherapy : CII|June 15, 2007
An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancerFrancesca Milano, Agnieszka M Rygiel, Navtej Buttar, et al.
Clinical Genitourinary Cancer|October 29, 2017
The Contemporary Use of Radium-223 in Metastatic Castration-resistant Prostate CancerDaniel Heinrich, Jasmin Bektic, Andries M Bergman, et al.
Glia|April 4, 2022
Survival motor neuron protein deficiency alters microglia reactivityGuzal Khayrullina, Zaida A Alipio-Gloria, Marc-Olivier Deguise, et al.
Pageof 91